These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 17278050)

  • 21. Phototoxic dermatoses in pediatric BMT patients receiving voriconazole.
    Goyal RK; Gehris RP; Howrie D; Cogley KM; Windreich RM; Venkataramanan R
    Pediatr Blood Cancer; 2014 Jul; 61(7):1325-8. PubMed ID: 24619922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Voriconazole therapy in children with cystic fibrosis.
    Hilliard T; Edwards S; Buchdahl R; Francis J; Rosenthal M; Balfour-Lynn I; Bush A; Davies J
    J Cyst Fibros; 2005 Dec; 4(4):215-20. PubMed ID: 16243008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lupus-like lesions in a 28-month-old boy with chronic granulomatous disease on long-term voriconazole prophylaxis.
    Geller L; Raciti PM; Mercer SE; Phelps RG
    J Cutan Pathol; 2011 Aug; 38(8):677-8. PubMed ID: 21518384
    [No Abstract]   [Full Text] [Related]  

  • 24. The safety of voriconazole.
    Potoski BA; Brown J
    Clin Infect Dis; 2002 Nov; 35(10):1273-5. PubMed ID: 12410490
    [No Abstract]   [Full Text] [Related]  

  • 25. Adverse reactions to voriconazole.
    Boyd AE; Modi S; Howard SJ; Moore CB; Keevil BG; Denning DW
    Clin Infect Dis; 2004 Oct; 39(8):1241-4. PubMed ID: 15486850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voriconazole-associated phototoxicity.
    Riahi RR; Cohen PR
    Dermatol Online J; 2011 Feb; 17(2):15. PubMed ID: 21382298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl.
    Racette AJ; Roenigk HH; Hansen R; Mendelson D; Park A
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S81-5. PubMed ID: 15858516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lupus erythematosus-like lesions by voriconazole in an infant with chronic granulomatous disease.
    Gomez-Moyano E; Vera-Casaño A; Moreno-Perez D; Sanz-Trelles A; Crespo-Erchiga V
    Pediatr Dermatol; 2010; 27(1):105-6. PubMed ID: 20199430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.
    Wermers RA; Cooper K; Razonable RR; Deziel PJ; Whitford GM; Kremers WK; Moyer TP
    Clin Infect Dis; 2011 Mar; 52(5):604-11. PubMed ID: 21239842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Painful peripheral neuropathy associated with voriconazole during the treatment of chronic cavitary pulmonary aspergillosis].
    Gendrot A; de La Blanchardière A; de La Gastine B; Fromager G; Massias L; Verdon R
    Rev Med Interne; 2010 Feb; 31(2):163-6. PubMed ID: 19457596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA
    J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voriconazole in newborns.
    Kohli V; Taneja V; Sachdev P; Joshi R
    Indian Pediatr; 2008 Mar; 45(3):236-8. PubMed ID: 18367773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.
    Zwald FO; Spratt M; Lemos BD; Veledar E; Lawrence C; Marshall Lyon G; Chen SC
    Dermatol Surg; 2012 Aug; 38(8):1369-74. PubMed ID: 22551390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole.
    Ibrahim SF; Singer JP; Arron ST
    Dermatol Surg; 2010 Nov; 36(11):1752-5. PubMed ID: 20533939
    [No Abstract]   [Full Text] [Related]  

  • 35. Torsades de pointes associated with voriconazole use.
    Philips JA; Marty FM; Stone RM; Koplan BA; Katz JT; Baden LR
    Transpl Infect Dis; 2007 Mar; 9(1):33-6. PubMed ID: 17313469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.
    Ayub A; Kenney CV; McKiernan FE
    J Clin Rheumatol; 2011 Mar; 17(2):73-5. PubMed ID: 21169844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient.
    Tedja R; El-Sherief A; Olbrych T; Gordon S
    Transpl Infect Dis; 2013 Aug; 15(4):424-9. PubMed ID: 23663268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Voriconazole-induced pseudoporphyria.
    Tolland JP; McKeown PP; Corbett JR
    Photodermatol Photoimmunol Photomed; 2007 Feb; 23(1):29-31. PubMed ID: 17254033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the "therapeutic range" for voriconazole?
    Lewis RE
    Clin Infect Dis; 2008 Jan; 46(2):212-4. PubMed ID: 18171252
    [No Abstract]   [Full Text] [Related]  

  • 40. Lack of cross-hepatotoxicity between voriconazole and posaconazole.
    Foo H; Gottlieb T
    Clin Infect Dis; 2007 Sep; 45(6):803-5. PubMed ID: 17712772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.